Comparing Oral Metronidazole VS Oral Metronidazole with Oral Probiotics in the treatment of Bacterial vaginosis

A Comparative study on the efficacy of Oral Metronidazole VS Oral Metronidazole with ORAL Probiotics in the management of Bacterial Vaginosis - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073504

Enrollment

Registered

2024-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: oral metronidazole: Oral Metronidazole 400 mg BD daily for 1 week Control Intervention1: oral metronidazole with oral probiotics: Oral Metronidazole 400mg BD daily for 1 week plus oral

Eligibility

Inclusion criteria

Inclusion criteria: Patient with more than 18 years of age Patient with complaints of vaginal discharge satisfying Amsel criteria Patient willing for consent, study and regular follow up Patient willing to take photograph

Exclusion criteria

Exclusion criteria: Patients below 18 years. Patients with sexually transmitted diseases such as HIV , Syphilis, Hepatitis B and Hepatitis C Patient with vaginal discharge due to co-existing genital ulcer Patient with other infective causes of vaginal discharge such as Trichomonas vaginitis, vulvovaginal candidiasis Patients who are on treatment with any antibiotics 6 weeks prior to the study Lactating or Pregnant women

Design outcomes

Primary

Measure	Time frame
clinical and microbiological cureTimepoint: 1 year	—

Secondary

Measure	Time frame
decreases the recurrencesTimepoint: 1 year	—

Countries

India

Contacts

Public ContactSoundharya G

Government Stanley Medical College

jay11079@gmail.com9600694059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026